本文言語 | 英語 |
---|---|
ページ(範囲) | 338-341 |
ページ数 | 4 |
ジャーナル | Diabetology International |
巻 | 7 |
号 | 4 |
DOI | |
出版ステータス | 出版済み - 12月 1 2016 |
!!!All Science Journal Classification (ASJC) codes
- 内科学
- 内分泌学、糖尿病および代謝内科学
UN SDG
この成果は、次の持続可能な開発目標に貢献しています
文献へのアクセス
他のファイルとリンク
引用スタイル
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Bilirubin as an important physiological modulator of oxidative stress and chronic inflammation in metabolic syndrome and diabetes : a new aspect on old molecule. / Inoguchi, Toyoshi; Sonoda, Noriyuki; Maeda, Yasutaka.
In: Diabetology International, Vol. 7, No. 4, 01.12.2016, p. 338-341.研究成果: ジャーナルへの寄稿 › 編集 › 査読
}
TY - JOUR
T1 - Bilirubin as an important physiological modulator of oxidative stress and chronic inflammation in metabolic syndrome and diabetes
T2 - a new aspect on old molecule
AU - Inoguchi, Toyoshi
AU - Sonoda, Noriyuki
AU - Maeda, Yasutaka
N1 - Funding Information: T. Inoguchi received speaker honoraria from Boehringer Ingelheim GmbH, Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Pharma Ltd., Taisho Toyama Pharmaceutical Co. Ltd., Sanofi K.K., Astellas Pharma Inc., Kowa Pharmaceutical Co. Ltd., Novartis Pharma K.K., AstraZeneca K.K., Ono Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Eli Lilly Co. Ltd., Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd. N. Sonoda received speaker honoraria from Takeda Pharmaceutical Co. Ltd., AstraZeneca K.K., Mitsubishi Tanabe Pharma Corporation. T. Inoguchi received scholarship grants from Dainippon Sumitomo Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Astellas Pharma Inc., Ono Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd., Taisho Toyama Pharmaceutical Co. Ltd., Novo Nordisk Pharma Ltd., Eli Lilly Co. Ltd. Y. Maeda has no conflict of interest.
PY - 2016/12/1
Y1 - 2016/12/1
UR - http://www.scopus.com/inward/record.url?scp=85001968633&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85001968633&partnerID=8YFLogxK
U2 - 10.1007/s13340-016-0288-5
DO - 10.1007/s13340-016-0288-5
M3 - Editorial
AN - SCOPUS:85001968633
VL - 7
SP - 338
EP - 341
JO - Diabetology International
JF - Diabetology International
SN - 2190-1678
IS - 4
ER -